CRC has an immunosuppressive TME which stops the event of a highly effective reaction to ICB therapies. There exists Therefore an urgent really need to identify the means reprogram this suppressive TME to be able to greatly enhance immunotherapy efficacy. In The present review, we made use of CRISPR KO https://davidc075sxa8.humor-blog.com/profile